Detalhe da pesquisa
1.
Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death.
Mol Cancer
; 13: 85, 2014 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24741998
2.
Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome.
Oncoimmunology
; 9(1): 1760705, 2020 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923120
3.
Prevalence of indolent systemic mastocytosis in a Dutch region.
J Allergy Clin Immunol
; 131(5): 1429-31.e1, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23219169
4.
CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαß+ CD8αß+ T cells that can be targeted for cancer immunotherapy.
Oncotarget
; 7(46): 75130-75144, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27650547